What is ArcScan?
ArcScan is at the forefront of advancing ophthalmic imaging through its innovative robotic ultrasound technology. The company's primary focus is on enhancing imaging capabilities for refractive surgery, offering a sophisticated solution that aids in precise surgical planning. Their flagship product, the Insight 100, is designed to deliver detailed anatomical insights, thereby increasing clinical confidence and improving patient outcomes. ArcScan aims to equip ophthalmic practices with advanced tools for better diagnostic and treatment decisions, targeting surgeons and clinics dedicated to cutting-edge eye care.
How much funding has ArcScan raised?
ArcScan has raised a total of $3.7M across 1 funding round:
Private Equity
$3.7M
Private Equity (2015): $3.7M, investors not publicly disclosed
What's next for ArcScan?
The recent major strategic investment signals a pivotal growth phase for ArcScan, likely enabling the company to scale its operations, further develop its robotic ultrasound technology, and expand its market reach within the ophthalmic sector. This capital infusion is expected to accelerate product development and adoption, solidifying ArcScan's position as a key player in enhancing surgical planning and patient care through advanced imaging solutions.
See full ArcScan company page
